drugset / Trial / NCT06874673

Summary

Pronase is a proteolytic enzyme known for its ability to clear mucus by breaking down its main component, mucin, through enzymatic hydrolysis. This property makes it useful in gastroscopy, where it is employed to improve the visibility of the mucosal surface during endoscopic examinations. Given the same mechanism, pronase may also be beneficial in enhancing mucosal clarity during colonoscopy. This multicenter, prospective, double-blind randomized controlled trial is designed to assess the effectiveness and safety of pronase in improving mucosal visibility in patients with colitis during endoscopy.

Timeline

Start
2025-03-17
Primary completion
2025-09-30
Completion
2025-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Promethazine Small molecule 200 unknown Other

Indications

No indication recorded.